Why the study?
Does continuation of warfarin therapy increase the risk of significant perioperative haemorrhage or thromboembolic phenomena during cataract surgery?
Does continuation of warfarin therapy increase the risk of significant perioperative haemorrhage or thromboembolic phenomena during cataract surgery?
Warfarin therapy should not be ceased perioperatively for cataract surgery, as the risk of visually significant haemorrhage is low and continuation prevents serious thromboembolic events.
No takes yet. Share an insight, caveat, or question.
May support warfarin continuation in cataract surgery; leaves open need for randomized confirmation of thromboembolic safety.
Morris et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: